Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Ambrisentan plus Spironolactone
(D00443)		2件: Ambrisentan,
Spironolactone		2件: Spironolactone (D00443),
Ambrisentan 💬		2件: EDNRA,
NR3C2 💬		8件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬
2Spironolactone
(D00443)		1件: Spironolactone1件: Spironolactone (D00443) 💬1件: NR3C2 💬1件: Aldosterone-regulated sodium reabsorption 💬8件: 46, 58, 67, 86, 113, 210, 218, 225 💬
3Spironolactone (drug)
(D00443)		1件: Spironolactone1件: Spironolactone (D00443) 💬1件: NR3C2 💬1件: Aldosterone-regulated sodium reabsorption 💬1件: 210 💬
4Spironolactone and conivaptan
(D00443)		2件: Conivaptan,
Spironolactone		2件: Spironolactone (D00443),
Conivaptan 💬		3件: AVPR1A,
AVPR2,
NR3C2 💬		6件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬1件: 86 💬
5Spironolactone captopril carvedilol
(D00443)		3件: Captopril,
Carvedilol,
Spironolactone		3件: Captopril ,
Carvedilol ,
Spironolactone (D00443) 💬		7件: ACE,
ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2,
NR3C2 💬		19件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 86 💬